The first preclinical evidence of a beneficial effect of targeting polyamine metabolism in Hh-induced BCC was documented in mice carrying heterozygous deletion of the Ptch1 gene (Ptch1+/−). Here, PTCH1 is linked to skin basal cell carcinoma.